Workflow
Sarepta Stock Tumbles 40%. Why the Biotech's Shares Are Sinking.
Sarepta TherapeuticsSarepta Therapeutics(US:SRPT) Barrons·2025-11-04 19:20

The biotechnology company discloses disappointing trial data for two treatments for Duchenne muscular dystrophy. ...